Rusz Orsolya, Kószó Renáta Lilla, Dobi Ágnes, Csenki Melinda, Valicsek Erzsébet, Nikolényi Alíz, . . . Kahán Zsuzsanna. (2018). Clinical benefit of fulvestrant monotherapy in the multimodal treatment of hormone receptor and HER2 positive advanced breast cancer: A case series.
Chicago Style (17th ed.) CitationRusz Orsolya, Kószó Renáta Lilla, Dobi Ágnes, Csenki Melinda, Valicsek Erzsébet, Nikolényi Alíz, Uhercsák Gabriella, Cserháti Adrienn, and Kahán Zsuzsanna. Clinical Benefit of Fulvestrant Monotherapy in the Multimodal Treatment of Hormone Receptor and HER2 Positive Advanced Breast Cancer: A Case Series. 2018.
MLA idézésRusz Orsolya, et al. Clinical Benefit of Fulvestrant Monotherapy in the Multimodal Treatment of Hormone Receptor and HER2 Positive Advanced Breast Cancer: A Case Series. 2018.